140 related articles for article (PubMed ID: 12956429)
1. Integrating B cell homeostasis and selection with BLyS.
Harless Smith S; Cancro MP
Arch Immunol Ther Exp (Warsz); 2003; 51(4):209-18. PubMed ID: 12956429
[TBL] [Abstract][Full Text] [Related]
2. Peripheral B-cell maturation: the intersection of selection and homeostasis.
Cancro MP
Immunol Rev; 2004 Feb; 197():89-101. PubMed ID: 14962189
[TBL] [Abstract][Full Text] [Related]
3. BLyS: the pivotal determinant of peripheral B cell selection and lifespan.
Harless Smith S; Cancro MP
Curr Pharm Des; 2003; 9(23):1833-47. PubMed ID: 12871188
[TBL] [Abstract][Full Text] [Related]
4. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers.
Harless SM; Lentz VM; Sah AP; Hsu BL; Clise-Dwyer K; Hilbert DM; Hayes CE; Cancro MP
Curr Biol; 2001 Dec; 11(24):1986-9. PubMed ID: 11747827
[TBL] [Abstract][Full Text] [Related]
5. Peripheral B cell selection and homeostasis.
Cancro MP; Smith SH
Immunol Res; 2003; 27(2-3):141-8. PubMed ID: 12857963
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors.
Smith SH; Cancro MP
J Immunol; 2003 Jun; 170(12):5820-3. PubMed ID: 12794106
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.
Yan M; Brady JR; Chan B; Lee WP; Hsu B; Harless S; Cancro M; Grewal IS; Dixit VM
Curr Biol; 2001 Oct; 11(19):1547-52. PubMed ID: 11591325
[TBL] [Abstract][Full Text] [Related]
8. Space, selection, and surveillance: setting boundaries with BLyS.
Miller JP; Stadanlick JE; Cancro MP
J Immunol; 2006 Jun; 176(11):6405-10. PubMed ID: 16709796
[TBL] [Abstract][Full Text] [Related]
9. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.
Hondowicz BD; Alexander ST; Quinn WJ; Pagán AJ; Metzgar MH; Cancro MP; Erikson J
Int Immunol; 2007 Apr; 19(4):465-75. PubMed ID: 17369193
[TBL] [Abstract][Full Text] [Related]
10. B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.
Nardelli B; Moore PA; Li Y; Hilbert DM
Leuk Lymphoma; 2002 Jul; 43(7):1367-73. PubMed ID: 12389615
[TBL] [Abstract][Full Text] [Related]
11. B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.
Smith SH; Haas KM; Poe JC; Yanaba K; Ward CD; Migone TS; Tedder TF
Int Immunol; 2010 Aug; 22(8):681-91. PubMed ID: 20513733
[TBL] [Abstract][Full Text] [Related]
12. Immunology. Long live the mature B cell--a baffling mystery resolved.
Waldschmidt TJ; Noelle RJ
Science; 2001 Sep; 293(5537):2012-3. PubMed ID: 11557866
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.
Hsu BL; Harless SM; Lindsley RC; Hilbert DM; Cancro MP
J Immunol; 2002 Jun; 168(12):5993-6. PubMed ID: 12055205
[TBL] [Abstract][Full Text] [Related]
14. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J
J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583
[TBL] [Abstract][Full Text] [Related]
15. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation.
Cancro MP
Immunol Rev; 2004 Dec; 202():237-49. PubMed ID: 15546397
[TBL] [Abstract][Full Text] [Related]
16. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.
Moore PA; Belvedere O; Orr A; Pieri K; LaFleur DW; Feng P; Soppet D; Charters M; Gentz R; Parmelee D; Li Y; Galperina O; Giri J; Roschke V; Nardelli B; Carrell J; Sosnovtseva S; Greenfield W; Ruben SM; Olsen HS; Fikes J; Hilbert DM
Science; 1999 Jul; 285(5425):260-3. PubMed ID: 10398604
[TBL] [Abstract][Full Text] [Related]
17. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
Jelinek DF; Darce JR
Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725
[TBL] [Abstract][Full Text] [Related]
18. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.
Vugmeyster Y; Seshasayee D; Chang W; Storn A; Howell K; Sa S; Nelson T; Martin F; Grewal I; Gilkerson E; Wu B; Thompson J; Ehrenfels BN; Ren S; Song A; Gelzleichter TR; Danilenko DM
Am J Pathol; 2006 Feb; 168(2):476-89. PubMed ID: 16436662
[TBL] [Abstract][Full Text] [Related]
19. To B or not to B: TNF family signaling in lymphocytes.
Siegel RM; Lenardo MJ
Nat Immunol; 2001 Jul; 2(7):577-8. PubMed ID: 11429537
[TBL] [Abstract][Full Text] [Related]
20. BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target.
Baker KP
Autoimmun Rev; 2004 Jul; 3(5):368-75. PubMed ID: 15288003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
